After Regeneron announced its monoclonal antibody treatment could be less effective against the omicron variant of COVID-19, the state of Texas might eventually be forced to shift its strategy in fighting the virus. READ MORE: [ Ссылка ]
Stay informed about Austin and Central Texas news, weather, investigations and sports on our website and social media:
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
